Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract

被引:0
作者
George Miller
Nicholas D Socci
Deepti Dhall
Michael D'Angelica
Ronald P DeMatteo
Peter J Allen
Bhuvanesh Singh
Yuman Fong
Leslie H Blumgart
David S Klimstra
William R Jarnagin
机构
[1] New York University School of Medicine,Department of Surgery and Cell Biology
[2] Memorial Sloan-Kettering Cancer Center,Department of Biostatistics
[3] Memorial Sloan-Kettering Cancer Center,Department of Pathology
[4] Memorial Sloan-Kettering Cancer Center,Department of Surgery
来源
Journal of Experimental & Clinical Cancer Research | / 28卷
关键词
Comparative Genomic Hybridization; Biliary Tract Cancer; Biliary Cancer; Comparative Genomic Hybridization Analysis; Biliary Tract Carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 166 条
[1]  
Randi G(2006)Gallbladder cancer worldwide: geographical distribution and risk factors Int J Cancer 118 1591-602
[2]  
Franceschi S(1996)Risk factors for gallbladder cancer. An international collaborative case-control study Cancer 78 1515-7
[3]  
La VC(2001)Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg 234 507-17
[4]  
Serra I(2003)Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies Cancer 98 1689-700
[5]  
Calvo A(2001)Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes J Am Coll Surg 193 384-91
[6]  
Baez S(2005)Genetic alterations in gallbladder carcinoma Surg Today 35 101-5
[7]  
Yamamoto M(2002)K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China Clin Cancer Res 8 3156-63
[8]  
Endoh K(2003)Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells Cancer Res 63 1083-92
[9]  
Aranda W(2002)ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions Hepatology 36 439-50
[10]  
Jarnagin WR(2005)Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells Hepatology 42 1329-38